What is the clinical evidence from this study?

Study design: Case Report. Population: Symptomatic hypertrophic obstructive cardiomyopathy (HOCM) (n=2). Intervention: Intraprocedural myocardial contrast echocardiography (MCE). Primary outcome: Identification of the correct ablation area.

What does this research mean for the field?

Intraprocedural myocardial contrast echocardiography identifies off-target vessel perfusion during percutaneous transluminal septal myocardial ablation, preventing distant myocardial necrosis and associated complications. Novelty: ClaimNovelty.INCREMENTAL. Consensus alignment: ConsensusAlignment.NEUTRAL.

August 1, 1999Catheterization and Cardiovascular Interventions

Intraprocedural myocardial contrast echocardiography as a routine procedure in percutaneous transluminal septal myocardial ablation: Detection of threatening myocardial necrosis distant from the septal target area

View Full Paper

Ask AI

Bookmark

Key result

Intraprocedural MCE guides targeted ablation to prevent fatal off-target necrosis in 2 cases.

Why the study?

Intraprocedural myocardial contrast echocardiography (MCE) can visualize the ablation area during PTSMA to prevent myocardial necrosis distant from the septal target area.

Does intraprocedural myocardial contrast echocardiography prevent off-target myocardial necrosis in patients undergoing percutaneous transluminal septal myocardial ablation for HOCM?

Comparison

Use of intraprocedural MCE to identify correct ablation area vs no MCE guidance

Design

Case report

Authors

LFLothar FaberHeart Failure & Transplant HSHubert SeggewißInterventional Cardiology PZPeer ZiemssenLeopoldina Krankenhaus Schweinfurt

Discussion

Member takes

Implication

May support intraprocedural MCE during PTSMA to avert off-target ablation; case reports leave open prospective validation in HOCM.

Study Design

Type

Case Report (n=2)

Structured PICO

Does intraprocedural myocardial contrast echocardiography prevent off-target myocardial necrosis in patients undergoing percutaneous transluminal septal myocardial ablation for HOCM?

Population

2 patients with symptomatic hypertrophic obstructive cardiomyopathy undergoing percutaneous transluminal septal myocardial ablation.

Intervention

Intraprocedural myocardial contrast echocardiography (MCE) prior to induction of chemical necrosis

Outcome

Identification of correct ablation area and avoidance of off-target necrosissafety

Intraprocedural myocardial contrast echocardiography during PTSMA is crucial for identifying off-target perfusion, allowing for target vessel correction and prevention of fatal complications.

Cite This Study

Faber et al. (1999) conducted a case report in Symptomatic hypertrophic obstructive cardiomyopathy (HOCM) (n=2). Intraprocedural myocardial contrast echocardiography (MCE) was evaluated on Identification of the correct ablation area. Intraprocedural myocardial contrast echocardiography successfully identified the correct ablation area in two patients, avoiding potentially fatal complications from distant myocardial necrosis.

synapsesocial.com/papers/6ab21b28dae2bc6b37c873c1 https://doi.org/10.1002/(sici)1522-726x(199908)47:4<462::aid-ccd16>3.0.co;2-9

Topics

Echocardiography Hypertrophic cardiomyopathy

View Full Paper

Ask AI

Bookmark

Intraprocedural myocardial contrast echocardiography as a routine procedure in percutaneous transluminal septal myocardial ablation: Detection of threatening myocardial necrosis distant from the septal target area

Discussion

Member takes

Implication

Study Design

Structured PICO

Cite This Study

Topics

Intraprocedural myocardial contrast echocardiography as a routine procedure in percutaneous transluminal septal myocardial ablation: Detection of threatening myocardial necrosis distant from the septal target area

Discussion

Member takes

Implication

Study Design

Structured PICO

Cite This Study

Also Consider

Topics

Also Consider